|
ANKIB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.152000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.241550E-02 |
| Normal-vs-Stage2 |
2.831200E-01 |
| Normal-vs-Stage3 |
6.657200E-01 |
| Normal-vs-Stage4 |
9.317400E-01 |
| Stage1-vs-Stage2 |
8.125200E-01 |
| Stage1-vs-Stage3 |
1.076150E-01 |
| Stage1-vs-Stage4 |
3.711900E-02 |
| Stage2-vs-Stage3 |
4.464400E-01 |
| Stage2-vs-Stage4 |
2.939800E-01 |
| Stage3-vs-Stage4 |
6.759600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.956100E-02 |
| Normal-vs-AfricanAmerican |
9.398400E-01 |
| Normal-vs-Asian |
2.482200E-01 |
| Caucasian-vs-AfricanAmerican |
2.777000E-01 |
| Caucasian-vs-Asian |
2.031600E-01 |
| AfricanAmerican-vs-Asian |
1.618960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.489000E-01 |
| Normal-vs-Female |
5.57279999999771E-05 |
| Male-vs-Female |
2.06899999999344E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.057800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.004050E-02 |
| Normal-vs-Age(61-80Yrs) |
3.852400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.902200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.707000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.373200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.258600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.922100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.036200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.771000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.041200E-01 |
| Normal-vs-Grade 2 |
2.453500E-02 |
| Normal-vs-Grade 3 |
7.067800E-02 |
| Normal-vs-Grade 4 |
2.664800E-01 |
| Grade 1-vs-Grade 2 |
3.799800E-01 |
| Grade 1-vs-Grade 3 |
2.402400E-01 |
| Grade 1-vs-Grade 4 |
1.935700E-02 |
| Grade 2-vs-Grade 3 |
6.269400E-01 |
| Grade 2-vs-Grade 4 |
7.604700E-03 |
| Grade 3-vs-Grade 4 |
2.886300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.47619999954796E-08 |
| Normal-vs-ccB subtype |
2.251200E-01 |
| ccA subtype-vs-ccB subtype |
8.0008000225007E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.588380E-02 |
| Normal-vs-N1 |
8.279200E-01 |
| N0-vs-N1 |
5.646200E-01 |
|
|
